- Home
- ALRN vs STCN Comparison
ALRN vs STCN Comparison
Compare ALRN & STCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALRN
- STCN
- Stock Information
- Founded
- ALRN 2001
- STCN 1986
- Country
- ALRN United States
- STCN United States
- Employees
- ALRN N/A
- STCN N/A
- Industry
- ALRN Biotechnology: Pharmaceutical Preparations
- STCN Advertising
- Sector
- ALRN Health Care
- STCN Consumer Discretionary
- Exchange
- ALRN Nasdaq
- STCN Nasdaq
- Market Cap
- ALRN 76.9M
- STCN 63.4M
- IPO Year
- ALRN 2017
- STCN 1994
- Fundamental
- Price
- ALRN $3.42
- STCN $9.80
- Analyst Decision
- ALRN Strong Buy
- STCN
- Analyst Count
- ALRN 1
- STCN 0
- Target Price
- ALRN $19.00
- STCN N/A
- AVG Volume (30 Days)
- ALRN 93.8K
- STCN 30.8K
- Earning Date
- ALRN 11-26-2024
- STCN 12-12-2024
- Dividend Yield
- ALRN N/A
- STCN N/A
- EPS Growth
- ALRN N/A
- STCN 203.29
- EPS
- ALRN N/A
- STCN 3.11
- Revenue
- ALRN N/A
- STCN $174,109,000.00
- Revenue This Year
- ALRN N/A
- STCN N/A
- Revenue Next Year
- ALRN N/A
- STCN N/A
- P/E Ratio
- ALRN N/A
- STCN $3.27
- Revenue Growth
- ALRN N/A
- STCN N/A
- 52 Week Low
- ALRN $1.57
- STCN $7.36
- 52 Week High
- ALRN $7.42
- STCN $13.00
- Technical
- Relative Strength Index (RSI)
- ALRN 47.41
- STCN 40.83
- Support Level
- ALRN $3.37
- STCN $9.66
- Resistance Level
- ALRN $3.92
- STCN $10.32
- Average True Range (ATR)
- ALRN 0.35
- STCN 0.61
- MACD
- ALRN -0.06
- STCN -0.02
- Stochastic Oscillator
- ALRN 21.36
- STCN 8.81
About ALRN Aileron Therapeutics Inc.
Aileron Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in patients with cancer that harbors p53 mutations to reduce or eliminate chemotherapy-induced side effects. The company currently has two product candidates in clinical development, LTI-03 and LTI-01, and multiple candidates in preclinical development focused on fibrosis indications.
About STCN Steel Connect Inc.
Steel Connect Inc is a diversified holding company. The company's operating segment include Direct Marketing and Supply Chain. It generates maximum revenue from the Direct Marketing segment. Geographically, it derives a majority of revenue from the United States and also has a presence in China; Netherlands, and others. The company serves clients in various industries including consumer electronics, communications, computing, software, storage, and retail industries.